Artificial intelligence for new drug discovery
Iktos has raised €16M across 1 funding round from 3 investors, most recently a Series A round in Mar 2023. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-03-09 | Series A | €16M |
| Debiopharm Innovation Fund,M Ventures,Omnes Capital |
| View deal → |
